glp-1 rheumatoid arthritis study Glucagon-like Peptide-1 Receptor Agonists in Arthritis: A Scoping Review of Metabolic, Anti-Inflammatory, and Cardioprotective Effects GLP-1 Medications and Rheumatoid Arthritis:

Gastrointestinal (GI) symptoms such as nausea, vomiting, constipation, and diarrhea are the most common adverse effects of GLP-1 therapies and are a leading cause of treatment discontinuation

Quick Answer: Leg cramps are not listed as an official side effect of semaglutide in FDA labeling, but may occur indirectly through dehydration, electrolyte imbalances, or nutritional changes associated with treatment

Clinical trial data and post-marketing surveillance indicate that a subset of patients experience decreased energy, tiredness, and general malaise while taking these medications

doi: 10.17116/jnevro2023123051100 26 QinLNiuJYZhouJYZhangQJZhouFZhangNet al

This price point may influence future commercial negotiations and could ultimately help bring costs down across the entire market